4932.5000 26.00 (0.53%)
NSE Jun 30, 2025 09:55 AM
Volume: 14,668
 

4932.50
0.53%
HDFC Securities
Maintain BUY with a revised TP of Rs 2,340 (22x Dec-20E EPS). Alkems 3QFY19 performance was in line with our expectations. A softer acute season led to a 1% fall in the domestic business, while the 44% jump in the US helped in maintaining 10% plus YoY top line growth. Poor business mix (lower India sales) and increased raw material cost led to a ~680bps drop in gross margin. As a result, EBITDA margin shrunk 450bps YoY and EBITDA declined 13% to Rs 3.1bn. Reported PAT at Rs 2.1bn was up 14% YoY owing to higher taxes in 3QFY18
Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended